TP53 and hepatocellular carcinoma: However, miR-22 downregulation was associated with poor prognosis and survival and with p53 (TP53) mutations in human cohorts, while our histopathological analyses of tumors in our mouse model revealed a higher incidence of HCC with poorly differentiated features in miR-22KO mice compared to WT littermates.